Portfolio company
Aikium
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops artificial intelligence and synthetic biology platforms to design and screen protein therapeutic libraries for biotechnology and pharmaceutical partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Generate Biomedicine
This company develops protein-based therapeutics using a generative artificial intelligence platform for pharmaceutical partners and biotechnology firms.
UbiquiTx
This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.
DeepSeq.AI
DeepSeq.AI develops an artificial intelligence platform for protein drug discovery and biologics design for pharmaceutical and biotechnology companies.
Nabla Bio
This company develops generative artificial intelligence and high-throughput screening platforms to design therapeutic antibodies for pharmaceutical and biotechnology partners.
Ionlace
This company develops an artificial intelligence platform for designing and producing novel proteins for the biotechnology and pharmaceutical industries.
Synteny Biotechnology
The company develops generative AI platforms to design programmable protein therapeutics and precision immunology treatments for biotechnology researchers and pharmaceutical developers.
310.ai
This company develops generative artificial intelligence models to design novel proteins and biomolecules for pharmaceutical and biotechnology organisations.
Anthrogen
This company develops artificial intelligence models and experimental infrastructure to design modular proteins and biological machines for healthcare, industrial and climate applications.
